Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.545,46
0,09%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Monopar Therapeutics Inc (MNPR) Monopar Therapeutics Inc (MNPR) Notizie

MNPR

Monopar Therapeutics (MNPR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNPR
DataOraFonteTitoloSimboloCompagnia
31/05/202422:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNPRMonopar Therapeutics Inc
24/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNPRMonopar Therapeutics Inc
24/05/202414:00GlobeNewswire Inc.Monopar Announces CFO SuccessionNASDAQ:MNPRMonopar Therapeutics Inc
09/05/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNPRMonopar Therapeutics Inc
09/05/202413:00GlobeNewswire Inc.Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma PipelineNASDAQ:MNPRMonopar Therapeutics Inc
18/04/202414:00GlobeNewswire Inc.Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual MeetingNASDAQ:MNPRMonopar Therapeutics Inc
16/04/202414:00GlobeNewswire Inc.Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization FindingsNASDAQ:MNPRMonopar Therapeutics Inc
10/04/202414:00GlobeNewswire Inc.Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer PatientsNASDAQ:MNPRMonopar Therapeutics Inc
28/03/202412:00GlobeNewswire Inc.Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
05/03/202413:00GlobeNewswire Inc.Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma ProgramNASDAQ:MNPRMonopar Therapeutics Inc
27/02/202413:00GlobeNewswire Inc.Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical TrialNASDAQ:MNPRMonopar Therapeutics Inc
22/02/202413:00GlobeNewswire Inc.Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced CancersNASDAQ:MNPRMonopar Therapeutics Inc
20/02/202414:00GlobeNewswire Inc.Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced CancersNASDAQ:MNPRMonopar Therapeutics Inc
09/11/202313:00GlobeNewswire Inc.Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
01/11/202312:00GlobeNewswire Inc.Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual MeetingNASDAQ:MNPRMonopar Therapeutics Inc
10/10/202313:00GlobeNewswire Inc.Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities ConferenceNASDAQ:MNPRMonopar Therapeutics Inc
05/09/202313:00GlobeNewswire Inc.Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:MNPRMonopar Therapeutics Inc
10/08/202313:00GlobeNewswire Inc.Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
08/08/202313:00GlobeNewswire Inc.Monopar Provides Encouraging Camsirubicin Clinical Data UpdateNASDAQ:MNPRMonopar Therapeutics Inc
11/07/202313:00GlobeNewswire Inc.Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of SingaporeNASDAQ:MNPRMonopar Therapeutics Inc
28/06/202322:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNPRMonopar Therapeutics Inc
21/06/202313:00GlobeNewswire Inc.Monopar to Participate in the Radiopharma Forum by the Lake 2023NASDAQ:MNPRMonopar Therapeutics Inc
14/06/202313:00GlobeNewswire Inc.Monopar to Participate in the Maxim Group’s Healthcare Virtual ConferenceNASDAQ:MNPRMonopar Therapeutics Inc
02/06/202322:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MNPRMonopar Therapeutics Inc
01/06/202313:00GlobeNewswire Inc.Monopar Announces Encouraging Camsirubicin Phase 1b Trial UpdateNASDAQ:MNPRMonopar Therapeutics Inc
11/05/202313:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNPRMonopar Therapeutics Inc
11/05/202313:00GlobeNewswire Inc.Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent DevelopmentsNASDAQ:MNPRMonopar Therapeutics Inc
28/04/202322:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNPRMonopar Therapeutics Inc
04/04/202323:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNPRMonopar Therapeutics Inc
28/03/202313:00GlobeNewswire Inc.Monopar to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:MNPRMonopar Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MNPR

La tua Cronologia

COIN
CSE30EUR
CSE-30
LSE
HCSA
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network